Receptor-induced apoptosis is a complex signal transduction pathway involving numerous protein/protein interactions and post-transcriptional modifications. The response to death receptor stimulation varies significantly from one cell line to another and even from one cell to another within a given cell line. In this context, it is often difficult to assess whether the molecular mechanisms identified so far are sufficient to explain the rich quantitative observations now available, and to detect possible gaps in our understanding. This is precisely where computational systems biology approaches may contribute. In this chapter, we review studies done in this direction, focusing on those that provided significant insight on the functioning of this complex pathway by tightly integrating experimental and computational approaches.
Introduction
Apoptosis is a form of programmed cell death conserved among metazoans playing a central role in development and involved in many diseases. Notably, most successful non-surgical cancer therapies eventually result in the activation of apoptosis in cancer cells [1] . Apoptosis can be triggered internally (via an 'intrinsic' pathway) following DNA damage or other intrinsic stimuli, or externally (via an 'extrinsic' pathway) following the binding of 'death' ligands to 'death' receptors.
Receptor-induced apoptosis raised therapeutical interest as anti-cancer strategy for at least two reasons. Firstly it can be highly selective for certain cell types, ideally targeting only cancer cells. Secondly it does not require a functional p53 protein, which is frequently mutated in tumor cells, providing resistance to chemotherapeutic drugs relying on the DNA damage response. Several death ligand/receptor pairs exist. While TNF (and its receptors TNFRs) and CD95L (and its receptor CD95) were discovered first, TRAIL (and its receptors DRs) has the highest selectivity towards cancer cells [2] . From a largest perspective, the latter is also a reference system illustrating how complex circuits involving graded and competing molecular signals can generate binary decisions. Because of its high interest, both for systems biology and therapeutics, tremendous research efforts have been done to better understand its functioning [3] [4] [5] [6] [7] [8] .
The control and regulation of apoptosis involve many genes whose products mediate numerous protein/protein interactions, post-translational modifications, transcriptional regulations, etc., yielding a highly complex picture. The sensitivity of cells to a given death ligand stimulation is multi-factorial, and the effect of genetic perturbations on cell survival is highly context-dependent. As a result, the interpretation of results obtained on a specific cell line and for a few genetic perturbations or conditions is delicate and cannot be readily generalized. The system model paradigm is well suited to deal with this complexity. Computational approaches attempt to integrate known mechanisms and interactions into mathematical models, whose predictions can be used to propose new experiments for model validation. When applied to apoptosis, system level modeling, which started approximately 15 years ago, was indeed instrumental in improving our understanding of this complex process. This was achieved by tightly integrating data of increasing quality and by increasing the scope and/or level of details of models. Excellent reviews discuss these modeling works [9] [10] [11] [12] [13] [14] [15] .
Despite these achievements, important fundamental questions remain to be answered, especially on the role of phenotypic heterogeneity and how it impacts the response to, as well as how it is changed by, treatments by death ligands [16] . Why Importantly, the two last questions, while critical for understanding the efficiency of treatments, are starting to be addressed only since very recently [17, 18] . Here, we review the contributions of system modeling studies to our understanding of receptorinduced apoptosis with a specific focus towards those important questions. We do not aim to exhaustively describe all the modeling work done on receptor-induced apoptosis. Rather, we describe a few key studies that are highly illustrative of how system modeling approaches can provide decisive insights.
Modeling the biochemistry of receptor-induced apoptosis

Early efforts: from known players and reactions to a system model
Many proteins playing a key role in receptor-induced apoptosis are known since decades, together with a qualitative picture of how they interact, either to convey external death signals to promote the activation of the core executioners of apoptosis or on the contrary to act as 'inhibitors' or 'blockers' of death signaling. Figure 1 provides a schematic overview of apoptotic pathways.
Despite this qualitative knowledge, how precisely cell response emerges from protein interactions in different cell lines and in response to stimulations of different strengths was not well understood. This led Fussenegger and colleagues [19] , and later Eissing and colleagues [20] , to quantitatively interpret such qualitative schemes and translate them into mathematical models describing the kinetics of the underlying biochemical reactions using the simplest quantitative mathematical framework, ordinary differential equations (ODEs). Assuming specific values for parameters (reaction rate constants and protein initial concentrations) and specific initial conditions (initial protein concentrations), these models can be used to simulate the temporal evolution of molecular species concentrations.
These early studies did not quantitatively compared simulation results to data. Their explanatory power was therefore not well established. Still, by studying how simulated cell behaviors depend on the different parameters, these models provided interesting qualitative insights on the structure of the pathways, that is, on the molecular implementation of receptor-induced apoptosis. For example, Eissing and colleagues rightfully concluded from their model that there must be a caspase-8 inhibitor to allow for both 1) fast kinetics of apoptosis at sufficient stimulation levels and 2) the existence of a threshold stimuli intensity below which apoptosis is not triggered [20] . 
Tight integration of kinetic modeling and quantitative experimental data revealed key mechanistic features of receptor-induced apoptosis
After those early efforts, several groups employed approaches that integrated more tightly the construction and analysis of ODE models of receptor-induced apoptosis with experimental data. These approaches have been particularly fruitful. Indeed, they revealed several key mechanistic features of receptor-induced apoptosis.
A pioneering work for the systems biology of apoptosis is the study of CD-95 induced apoptosis by Bentele et al. [21] . By using an inhibitor of protein synthesis (cycloheximide or CHX) and exploiting differences in protein half-lives (cFLIP is short-lived whereas pro-caspase-8 is longlived), they decreased cFLIP levels while preserving pro-caspase-8 levels and observed the predicted significant decrease of the threshold needed to obtain cell death.
One main limitation of the approach by Bentele and colleagues is the use of population-level measurements for quantifying caspase activation. It was already known that the kinetics of caspase activation was different in different cells. More precisely, single-cell reporters for probing cytochrome c release [22] and effector caspase activation [23] revealed that these events are rapid and relatively invariant in terms of duration and intensity from one cell to another and for different stimulus, whereas their initiation times are highly variable. An important, although often implicit assumption in kinetic models of biochemical pathways is that they represent reactions taking place in individual cells: an enzyme in one cell does not catalyze reactions in another cell. Therefore, in presence of heterogeneity it is not appropriate to reason in terms of population-averaged quantities. Single-cell reporters enabling to measure the abundance or activity of biochemical species with live-cell imaging are therefore appealing tools to test and interrogate on a proper footing kinetic models.
And indeed, single-cell reporters in combination with kinetic modeling revealed a number of key mechanistic features of receptor-induced apoptosis.
The first study integrating kinetic modeling with such single-cell data investigated apoptosis induced by staurosporine [24] . Although staurosporine does not induce apoptosis via death receptors, it triggers MOMP (mitochondrial outer membrane permeabilization) and then a rapid, all-or-none effector caspase activation. These molecular events form the downstream part of both extrinsic and intrinsic apoptosis pathways. The authors focused on the events directly following MOMP, using realistic kinetics of cytochrome c and Smac release and apoptosome formation as inputs to their model, which then predicted effector caspase activation kinetics. The amount of XIAP was found to be a key factor in the kinetics of effector caspase activation following MOMP. Interestingly, the model predicted the existence of a small range of XIAP concentrations for which MOMP is followed by a slow and partial effector caspase activation, a prediction that was then confirmed experimentally.
Albeck and colleagues were the first to integrate, in a single model, initiator caspase activation (via TRAIL binding to death receptors), MOMP regulation and effector caspase activation [25] . The model featured 58 species (native protein and protein complexes) and 70 parameters (Figure 2 , top left). Instrumental in their work was the development of a single-cell reporter for initiator caspase activity [26] , which showed that this activity slowly rises at a variable rate between cells during the pre-MOMP period, and that despite this increasing activity, no significant effector caspase activity is observed; the latter arises suddenly and completely following MOMP 
Modeling populations of individual cells: the role of heterogeneity in protein levels
The previous studies shed light on how snap-action behaviors at the level of MOMP and effector caspase activation enable a tightly-constrained all-or-none control over apoptosis commitment. Such an all-or-none control is probably beneficial at the organism level, because partial effector caspase activation is genotoxic and could result it potential harmful mutations. But why different cells from the same cell line submitted to the same stimulus in the same conditions trigger MOMP after a highlyvariable delay from one another? Also, in most studies discussed so far, cells were co-treaded with the protein synthesis inhibitor cycloheximide (CHX). Blocking protein synthesis is interesting to disentangle the influence of signal transduction pathways from the influence of downstream genetic regulations. However, in these conditions, all cells eventually die, whereas in normal conditions, a fraction of the cell population often survives, a property of vital importance in the context of therapy. What are the origins of fractional killing? Are the mechanisms responsible for MOMP timing variability in treatments with CHX also involved in fractional killing without CHX?
An important study from the Sorger group brought key insights into these questions [28] . Using live-cell microscopy, the authors followed the fate of individual HeLa cells after exposure to TRAIL+CHX or TRAIL alone treatments. In both conditions, a significant variability was observed, in death times for TRAIL+CHX treatments, and in cell fate and death times for TRAIL alone treatments. Importantly, to investigate the role of differences in cell state that exist across cells at the time of treatment in determining cell fate and death times, they recorded normal cell proliferation for a duration of about one cell cycle before applying the treatment in order to identify 1) pairs of cells that are sisters and 2) how much time elapsed between their division and treatment. Such lineage information was exquisitely insightful (note that similar experimental observations were made earlier by Rehm et al. [29] and later by Bhola and Simons [30] ). First, in the TRAIL+CHX treatment, recently divided sister cells displayed a strong correlation in their death time, despite the high overall variability of death time among cells. This established that 1) death time variability is caused by pre-existing differences, conserved at cell division; and 2) in presence of CHX, TRAIL signaling is almost entirely deterministic (but again, depends on pre-existing differences). In other words, because one could accurately predict the fate of one recently-divided cell by observing the fate of its sister, there is no significant randomness in the signaling reactions taking place between TRAIL+CHX exposure and apoptosis commitment.
This led Spencer and colleagues to the hypothesis that differences in initial levels for proteins involved in TRAIL apoptotic signaling are the main determinants of cell fate variability. Mathematical modeling was used to test further this hypothesis (Figure 3 ).
They relied on the same kinetic ODE model (with minor modifications) of the proteinprotein reactions mediating TRAIL apoptotic signaling as in their previous study [25] .
However, instead of using a single population-averaged value for the initial level of each protein in the pathway, they created an in silico cell population by sampling many times protein levels from distributions, meant to reproduce the natural variability in protein levels within a population of HeLa cells (some of those distributions were actually measured experimentally using immuno-fluorescence and flow cytometry). Good agreement between model predictions and data for TRAIL+CHX treatments was then obtained (Figure 3) , therefore supporting that in these conditions initial variability in protein levels are the main determinants of the observed death time variability.
Additionally, when considering pairs of sister cells born long before TRAIL+CHX treatments, the correlation between their death times continuously decreases, showing that the cell determinants setting this death time fluctuate over time with a timescale of the order of a cell cycle. Notably, protein levels in human cells have been shown to fluctuate with similar time scales [31] . It is therefore probable that the natural slow fluctuations of protein levels are responsible for the decorrelation of sister cell fates after their division. For TRAIL alone treatments, a similar effect is seen, but firstly the correlation for recently-divided cells is reduced compared to TRAIL+CHX treatments, and secondly this correlation decreases markedly faster with sister cells' age. Because the primary effect of CHX is to block protein synthesis, this also strongly suggests that cell fate variability in TRAIL-induced apoptosis originates from synthesis-induced fluctuations in protein levels.
Note that by nature, the model used by Sorger and colleagues cannot account for the sister cell data, a limitation inherent to all deterministic models in which cell-to-cell differences are static, that is, cell-to-cell differences are modeled by distributions of values for initial protein concentrations or for time-invariant parameters. Such models do not explain how cell-to-cell variability can be generated, which is indispensable if re-establishment of cell-to-cell variability after TRAIL application should be understood. A prime candidate for the (re)generation of cell heterogeneity is stochastic protein fluctuations that are missed out in the previous approach. Note also that no attempt to reproduce cell fate variability data in TRAIL alone treatments, a critical observation, was made. One can cite two reasons. Firstly, the model was trained against TRAIL+CHX data, removing the influence of many parameters constraining protein production. Secondly, fractional killing was thought to result mostly from the activation of survival pathways and these pathways were not included in the model. Among the other modeling studies investigating cell-to-cell variability in receptorinduced apoptosis, it is worth mentioning the work by Toivonen and colleagues [32] .
These authors extended the model of CD-95L induced apoptosis from [21] 
Modeling different cell lines and their different sensitivities to receptor-induced apoptosis
From the discussion in the previous section, we have seen that differences in protein levels could be a main determinant of cell fate differences. Thus, knowing the expression levels of the proteins involved in extrinsic apoptosis in a given cell line could help predicting its sensitivity to different death ligand stimulations. Stated differently, we adopt here the viewpoint in which cell lines do not differ by the topology of their pathways but rather by the levels or more specifically by the distributions of the proteins involved in these pathways. This idea motivated another study by the Sorger group [33] . Using their previous model as a reference for the rates of biochemical reactions of extrinsic apoptosis, they studied the biochemical basis of the Type I / Type II behaviors. Type I (II) behavior refers to cells that do not require (do require) MOMP to commit to apoptosis after death ligand stimulation. As One limitation of the DLE analysis is that the DLE is a number that is difficult to interpret. It reflects a sensitivity of the future states to the initial conditions, but it does not give information about what is perturbed in the states. In addition, one has to choose a time horizon to compute DLEs, which might have a strong influence on the results. We have therefore proposed another approach, based on Signal Temporal Logic (STL) instead of DLE [34] . Temporal logics are flexible property specification languages that allow describing expected features of behaviors. Experimentallyobserved behaviors are explicitly encoded in STL. This approach allowed us to discover that the notion of Type I and Type II has limits, as there exist several interpretations of being a Type I or a Type II cell which are not equivalent (Figure 4 , bottom right).
The idea that differences in protein expression levels between cell lines could predict differences in response to death ligand stimulation from a mechanistic model of extrinsic apoptosis was also used in other studies [35] . Recently, a similar approach was applied to patient-derived cell lines to predict their sensitivity to treatment [36] , although here they used statistical modeling (rather than mechanistic modeling) to map expression profiles to sensitivity. 
Modeling fluctuations of protein levels to extend the temporal scope of existing models
Until now, the modeling approaches we have discussed represent the naturally- [18] . It relies on modeling stochastic gene expression (stochastic switches of the promoter between an active and an inactive transcriptional state, and stochastic production and degradation of the mRNA) and protein turnover for all (native) proteins appearing in the model. As a result, protein levels slowly fluctuate in each individual cell such that, overall, the distributions of the protein concentrations in the whole cell population are the ones observed in [28] .
This means that the naturally-occurring cell-to-cell variability, previously accounted by pre-determined distributions for initial protein concentrations, is now an emerging property of the model.
While such model extension a priori introduces many unknown parameters, we found that using simple constraints from the literature on parameter values one readily obtains good approximations of protein fluctuations for most proteins. Only shortlived proteins necessitate particular attention. This finding is a cornerstone of the approach, as it allows to strongly reduce the number of unconstrained parameters, facilitating exploration of the parameter space and reducing the risks of over-fitting. Results of the approach when applied to model and data of Spencer and colleagues [28] .
(C)
Simulation of consecutive TRAIL treatments reproduces the observed transient resistance acquisition [18] . Figure elements reproduced from [18] .
Conclusions and perspectives
In this chapter, we have surveyed how system modeling of receptor-induced apoptosis has been instrumental in improving our understanding of this process at several levels: the molecular level, the level of cellular decisions between life and death, and the level of cell populations exhibiting various degree of resistance as a function of their protein expression profiles or their treatment history.
More precisely, ordinary differential equations models recapitulating known reactions between proteins during apoptosis signaling are useful when compared to short-term Despite those promising advances, many questions remain without clear answers.
For example, while the important role in cell survival of the targeted degradation of many pro-and anti-apoptotic proteins is increasingly recognized [38] , accurate estimates of the corresponding rates are not available, and to which extent those rates fluctuate in single cells and vary from cell to cell is not known. Experiments using proteasome inhibitors are difficult to interpret because they have a global (but not necessarily identical) effect on all degradation rates. More targeted approaches (for example using specific single-cell reporters) could be very useful to better understand the role of targeted degradation in receptor-induced apoptosis.
While current models of receptor-induced apoptosis can be quite large (up to 100 species and reactions), they are often omitting structural details either because those details are not understood very well or because a simplifying representation is deliberately preferred. For example, the ligand-induced receptor clustering at cell surface, the processing of caspase-8 at the DISC, the role of the different Flip isoforms in that processing, and the interactions of all MOMP regulators at the mitochondrial surface, are generally significantly simplified. Such simplified representations can be accurate and therefore sufficient to address many questions.
Still, to test and improve our molecular-level understanding of receptor-induced apoptosis, more detailed mechanisms can be introduced into existing models, and model predictions can be compared to new data generated with adequate tools (such as relevant single-cell reporters). Without the 'right' data, increasing model complexity is probably vain.
Finally, while mathematical models of receptor-induced apoptosis start to address the question of long-term behavior of cell populations repeatedly treated by death receptor agonists, the amount and quality of corresponding experimental data is very scarce. Most in-vitro studies still only measure the efficiency of one-time treatment to model cell lines, and repeated treatments are only seen in mouse xenografts studies, in which time points and measurements are limited, and many effects related to the in-vivo context can affect the response. Quantitative population dynamics data (i.e., cell proliferation and death rate as a function of time) for cell lines cultured in-vitro and submitted to repeated treatments could prove very useful to better understand resistance acquisition, and to map it to molecular mechanisms with the aid of mathematical models. Also, the potential impact of spatial organization of the cells in tumors may generate further inhomogeneities that are not captured by models disregarding space, hence a full understanding will eventually have to explore the possible effects of space.
